PF-Atlas › Clinical Trials › NCT03258853
Feasibility of Outpatient Closed Loop Control With the iLet Bionic Pancreas in Cystic Fibrosis Related Diabetes
Bionic Pancreas · Not specified
Registry ID
NCT03258853
Phase
Not specified
Status
Completed
Drug / intervention
Bionic Pancreas
Sponsor
Massachusetts General Hospital
Start
2021-08-26
Enrollment
22
Locations
1
About this trial
The current study is designed to test the feasibility of the a wearable bionic pancreas system that automatically delivers insulin and glucagon can provide superior regulation of glycemia versus usual care for adults and children with cystic fibrosis related diabetes.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT03258853 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.